This is a working overview of RP-HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-20 and is reviewed periodically as new material appears.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Compared with older secretagogues such as hexarelin or GHRP-6, ipamorelin shows weaker stimulation of cortisol, prolactin, and appetite in the animal models used for early characterization. Whether that selectivity is preserved across longer human exposures remains an open question, because published clinical data are limited in size and duration. Reported effects on food intake are generally described as modest. The compound is therefore treated in the literature as a relatively selective research tool rather than a fully characterized therapeutic agent.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Researchers at a pharmaceutical company first described it in the 1990s while screening small peptides for growth hormone releasing activity. Its chain contains five amino acid residues, two of which are non-natural building blocks, including 2-aminoisobutyric acid and a naphthylalanine derivative. The molecule was designed to act at the ghrelin receptor while avoiding several effects observed with earlier secretagogues.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentapeptide | Growth hormone secretagogue family |
| Molecular mass | Approximately 711.9 Da | Free base, calculated value |
| Receptor target | GHS-R1a, the ghrelin receptor | Agonist activity reported |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | C-terminal amide |
| Reported selectivity | Little change in ACTH, cortisol, prolactin | Based mainly on animal data |
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
Identity and purity are assessed by complementary methods rather than a single test. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and reports a percentage purity. Mass spectrometry, most often with electrospray ionization, confirms the expected molecular mass and detects sequence-related variants. Amino acid analysis can verify composition, while water content and residual counterion measurements support the mass balance of a batch. Stability studies under accelerated conditions are used to estimate shelf life, though such estimates carry uncertainty for long-term storage.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.
== Composition == Tecemotide is a synthetic lipopeptide that is 27 amino acids long. Its molecular formula is C124H203N33O38, and its amino acid sequence is S T A PPAH G VTSAPDTRPAPGSTAPPKG. The first 25 amino acids of tecemotide are derived from the mucin 1 (MUC1, carcinoma-associated mucin, episialin, or CD227) sequence. The 26th modified amino acid, K, is palmityl-lysine (N6-(1-oxohexadecyl)-L-lysine), and the 27th is glycine.
==== Second Sino-Japanese War ==== Liu played on patriotic sentiment during the War of Resistance against Japan. In 1937, he attended a meeting of the Ya'an Anti-Japanese National Salvation Association, admitting his past "mistakes" in fighting other Chinese. He also donated a sum of 500,000 yuan to the war effort. However, while other Sichuan warlords such as Liu Xiang, Yang Sen, Li Jiayu, and Wang Mingzhang sent troops to fight the Japanese, Liu Wenhui refrained from doing the same, citing the need to defend the Tibetan frontier and a lack of equipment. Therefore, Liu Wenhui's 24th Army did not directly participate in the war. Instead, Liu's policy was that of "resisting Japan by building Xikang." According to the state-run New Xikang Post (新康報), the province complied with the wartime orders of the central government regarding resource and population mobilization. After the flight of the Nationalist government to Chongqing, Chiang became interested in establishing a presence in Xikang, proposing in either late 1938 or early 1939 to establish the "Xichang Headquarters" if ever Chongqing were to fall. To prepare for this task, he appointed Zhang Dulun, another of Liu's Baoding classmates, to lead the headquarters and moved the 36th (German-trained) division to Xichang. A power struggle developed in Xichang between Zhang and Liu, with Zhang attempting various measures to undermine Liu's control over Xichang.
=== Cross-linking micelles === Polymer-based micelles that undergo crosslinking reactions can induce the formation of nanogels. Crosslinking either the core or the shell of a preexisting micelles can synthesize nanogels with a "high degree of spatial organization".
=== Sources === Cortright, David (2008-04-24). Peace: A History of Movements and Ideas. Cambridge University Press. doi:10.1017/cbo9780511812675. ISBN 978-0-521-85402-3. Lederer, William J. (1958). The Ugly American. New York: W.W. Norton & Company. ISBN 978-0-393-31867-8. {{cite book}}: ISBN / Date incompatibility (help) Leibovitz, Liel (29 June 2018). "In Menachem Begin's Rise, Lessons for the #Resistance to Trump". Tablet. Shaw, Tony; Youngblood, Denise J. (2010). Cinematic Cold War. Kansas: University Press of Kansas. ISBN 978-0-7006-1743-2. Solzhenitsyn, Aleksandr Isaevič (1962). One Day in the Life of Ivan Denisovich. Signet classic. Harmondsworth, Middlesex: Penguin Books. ISBN 978-0-451-52310-5. {{cite book}}: ISBN / Date incompatibility (help) Whitfield, Stephen J. (1991). The Culture of the Cold War. Baltimore, MD: Johns Hopkins University Press. ISBN 978-0-8018-4081-4 – via Internet Archive. Wittner, Lawrence (2009-05-12). Confronting the Bomb: A Short History of the World Nuclear Disarmament Movement. Stanford, Calif: Stanford University Press. ISBN 978-0-8047-5631-0.
=== Healthcare === Cyclo Olefin Polymer (COP) is gaining adoption in medical, pharmaceutical and life science applications by replacing or being used in combination with other materials, yielding superior products. There is no risk of pH shift from released alkali ions as there is in glass containers making it suitable for long-term storage of sensitive pharmaceuticals such as protein- or peptide-based drugs. COP has excellent dimensional stability and can reproducibly replicate micron-sized features of microfluidic devices and diagnostics with high aspect ratios. In applications involving vacuum COP is amenable to coating with silica via plasma-enhanced chemical vapor deposition (PECVD). These coated materials are used for blood collection tubes (vacutainers) to reduce mass and improve safety for clinical workers. Similarly, coated COP vials are used for lyophilized (freeze-dried) proteins to give a more predictable and consistent heat flow rate during the lyophilization process. In applications requiring liquid nitrogen temperatures COP vials are used over glass or other plastics because of their durability over a range of temperatures and for extended periods of time, without impacting the viability of the stored material. This makes COP a suitable material for storing both biopharmaceutical drug products as well as stem cells for cell therapies.
Sources: en.wikipedia.org
=== House of Representatives === In 1968, Mizell was elected to represent the 5th District in the 91st United States Congress. He defeated Democratic nominee Smith Bagley, an R.J. Reynolds Tobacco Company official, 84,905 (52.4 percent) to 77,112 (47.6 percent). The previous 5th District representative, Democrat Nick Galifianakis, was moved to the 4th District for the 1968 elections. A supporter of Richard Nixon, Mizell ran on a platform vehemently opposed to federal spending and Communism. In his first term, he spoke in favor of trade legislation. "I believe no nation in the world need fear the Trade Bill of 1970," he said, praising it for its benefits to foreign nations and American workers alike.
Corruption index (-0.54) Control of corruption (0.47) Bureaucratic quality (0.40) PPP-adjusted GDP per capita (although there is evidence of publication bias) (0.39) Economic freedom (0.35) Human rights violations (-0.33) Political and ethnic violence (-0.28) Civil liberties (0.28) Life expectancy at birth (0.27) Satisfaction with standard of living (0.24)
== Personal life == A friend of his from high school introduced Watson to Judith Sjoberg. Not long after that, they were married and moved to Brooks Air Base in San Antonio, Texas. They had two children in Nashville, Jennifer, born in 1970, and Brent born in 1972.
For centuries, naturalists treated lichens as self-contained, plant-like organisms distinguished only by outward appearance. Theophrastus (c. 300 BC) introduced the word lichen for crusty bark growths, yet offered little insight beyond the name. Until the mid-1700s, taxonomists lumped lichens with algae, mosses, or fungi in broad, pre-evolutionary schemes. A pivotal step came in 1700, when the French botanist Joseph Pitton de Tournefort erected the genus Lichen, acknowledging the group's distinctiveness—even while keeping it beside mosses and liverworts. Robert Morison's 1699 Herbarium, for instance, split lichens into five "Muscofungi" types, a purely morphological scheme that left little mark on later work. The Italian polymath Pier Antonio Micheli published the first recognizable lichen classification in his 1729 Nova plantarum genera. While he kept all species in the catch‑all genus Lichen—echoing Tournefort—Micheli organized them into several "orders" based on thallus texture and fruiting body form. Those informal groupings later became the nuclei of modern genera, and his morphological terminology laid the groundwork for subsequent binomial treatments. In 1753 Carl Linnaeus introduced the first coherent plant-classification scheme in Species Plantarum. He listed roughly 80 lichen species, grouping almost all under the single genus Lichen. Such compression mirrored 18th-century ignorance of lichen diversity: 'lichen' was little more than a catch-all for crusty or leafy growths on bark and stone.
== Production == Argon is extracted industrially by the fractional distillation of liquid air in a cryogenic air separation unit; a process that separates liquid nitrogen, which boils at 77.3 K, from argon, which boils at 87.3 K, and liquid oxygen, which boils at 90.2 K. About 700,000 tonnes of argon are produced worldwide every year.
Sources: en.wikipedia.org
== Clinical significance == A prolonged stimulation of these cells causes their hyperplasia. This is especially important in gastrinoma (the tumors in which there is an excessive secretion of gastrin), as this is one of the factors contributing to Zollinger–Ellison's syndrome. It was once believed that tumors of ECL origin form after a prolonged inhibition of gastric acid secretion, however there is no data to support this conclusion and proton pump inhibitors are not thought to contribute to gastric cancer.
=== Beta-blockers === Many of the common symptoms of hyperthyroidism, such as palpitations, trembling, and anxiety, are mediated by increases in beta-adrenergic receptors on cell surfaces. Beta blockers, typically used to treat high blood pressure, are a class of drugs that offset this effect, reducing the rapid pulse associated with palpitations, and decreasing tremor and anxiety. Thus, a person with hyperthyroidism can often obtain immediate temporary relief until the hyperthyroidism can be characterized with the Radioiodine test noted above, and more permanent treatment takes place. Note that these drugs do not treat hyperthyroidism or any of its long-term effects if left untreated, but rather, they treat or reduce only symptoms of the condition. Some minimal effect on thyroid hormone production also comes with propranolol, which has two roles in the treatment of hyperthyroidism, determined by the different isomers of propranolol. L-propranolol causes beta-blockade, thus treating the symptoms associated with hyperthyroidism, such as tremor, palpitations, anxiety, and heat intolerance. D-propranolol inhibits thyroxine deiodinase, thereby blocking the conversion of T4 to T3, providing some, though minimal, therapeutic effect. Other beta-blockers are used to treat only the symptoms associated with hyperthyroidism. Propranolol in the UK, and metoprolol in the US, are most frequently used to augment treatment for people with hyperthyroidism.
Three more recent reviews reached similar conclusions: little evidence supporting the use of trigger point dry needling to treat upper shoulder pain and dysfunction, evidence not robust enough to draw a clear conclusion about safety and efficacy, and that dry needling for the treatment of myofascial pain syndrome in the lower back appeared to be a useful addition to standard therapies, but stated clear recommendations could not be made because the published studies were small and of low quality. However, a retrospective analysis of 2,910 dry needling interventions as reported by Mabry, et al. identified no reported safety events when dry needling was performed by physical therapists.
== Definition == Cachexia is hard to define because it often happens alongside malnutrition and sarcopenia. Since there are no clear rules separating these conditions, experts continue working to agree on definitions to help treat these nutrition-related problems. In the past, cachexia was described as "a complex metabolic syndrome associated with underlying illness and characterized by loss of muscle with or without loss of fat mass." In 2011, experts updated this definition, saying cachexia is "a multifactorial syndrome defined by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment." They also suggested breaking it into three stages: pre-cachexia, cachexia, and refractory cachexia.
On 25 February, Gnassingbé was nominated by delegates of the ruling party, the Rally for the Togolese People, as the party's presidential candidate. He was also chosen as head of the party. Shortly afterwards, under mounting domestic and international pressure, Gnassingbé announced that he would step down as president during the interim period and Bonfoh Abass was appointed by the National Assembly to replace him as acting president until the election on 24 April. Bonfoh was considered by some to be a puppet of the military elite and the Gnassingbé family. Gnassingbé competed with the main opposition candidate, Emmanuel Bob-Akitani, a retired engineer of the state-owned mining company and the second most important person in the opposition coalition after Gilchrist Olympio. Olympio could not take part in the election, since the constitution required that any candidate must have lived for at least 12 months in Togo, and Olympio had been in self-imposed exile for fear that he would be murdered by the Eyadema clan like his father. In the election, Gnassingbé received slightly more than 60% of the votes, according to official results. The RPT refused to allow oversight during the counting of the ballots. The EU and the Carter Center deemed the elections to be fraudulent. Mass protests by the coalition of opposition parties led to the killing of over 1,000 citizens by security forces. 40,000 refugees fled to neighboring Benin and Ghana.
Sources: en.wikipedia.org
Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release by activating the ghrelin receptor. It is handled as a research tool rather than as a licensed therapeutic product. Its short chain length makes it comparatively simple to synthesize and analyze.
Both bind the same receptor, but ghrelin is a 28-amino-acid hormone with roles in appetite and energy balance. Ipamorelin is a much smaller synthetic peptide selected for growth hormone release with limited effect on appetite signaling in animal models. The full overlap between their effects is not completely mapped.
Most published data come from animal studies and a small number of human trials. Findings on growth hormone release are reasonably consistent, while long-term effects and direct comparisons with other secretagogues remain incompletely studied. Open questions include duration of action across different populations.
It is a synthetic pentapeptide in the growth hormone secretagogue family. The chain contains five residues, two of which are non-natural amino acids.